Month: July 2016

Many patients with migraine use “complementary and alternative medicine” and often do not discuss this with their physicians. There have been guidelines from various professional societies, and recommendations often conflict. The greatest number of studies has been done with riboflavin, coenzyme Q10, magnesium, butterbur, feverfew, and omega-3 polyunsaturated fatty acids. Nutraceuticals are lightly regulated by… Read more »

There are now 4 monoclonal antibodies that block calcitonin gene-related peptide (CGRP) or its receptor in clinical trials. A post-hoc analysis of a phase II trial, which was reported in Lancet Neurology, November 2015, and showed positive results, now found that the highest dose of the medication shows an effect within the first 3 days… Read more »